FDA panel backs Daiichi's blood thinner

October 31, 2014 3:27 PM

13 0

FDA panel backs Daiichi's blood thinner

A panel of advisers to the U.S. Food and Drug Administration voted 9-1 in favor of approving Japanese drugmaker Daiichi Sankyo Co's blood thinner for use in some patients with atrial fibrillation.

The drug, edoxaban, is a once-daily anticoagulant that inhibits Factor Xa, a protein that plays a central role in blood-clotting. If approved, it would compete with three other medicines already vying to displace a decades-old treatment.

Read more

To category page